2013 Researcher Dr. Mark Ruschin

Comparison of healthy tissue sparing using different radiation delivery devices for focal irradiation of multiple brain metastases

Dr. Mark Ruschin brain tumour researcherDr. Mark Ruschin
Sunnybrook Odette Cancer Centre, Toronto, ON
Award: $18,500

Dr. Ruschin's project is funded in memory of and through the generosity of Donald J.T.A. de Jong



Project Summary:

Brain metastases occur in 20-40% of people with cancer, and will lead to over 7,000 diagnosed cases in 2013. For these individuals, quality of life is of the utmost importance. The traditional approach to managing patients with brain metastases is to perform whole brain radiation, in which the entire brain receives a uniform dose of radiation in order to stop the diagnosed brain metastases from growing, and to prevent new brain metastases from forming.

Whole brain radiotherapy, however, adversely affects cognitive function and limits further treatment should additional brain metastases develop. Focal radiation targets individual brain metastases and spares the healthy brain, which maintains better cognitive function and provides excellent tumor control. Various radiation therapy technologies are capable of focal radiation.

One new device has recently become Health Canada approved and exhibits improved characteristics over predecessors such as faster radiation delivery, and lower leakage radiation. We hypothesize that this new device can be used to treat patients with multiple brain metastases in a focal/ablative fashion, thus better preserving patients’ cognitive function and improving quality of life. The focus of this work is technique development and a comparison of radiation dose distributions to the current standard.

Final report:

The project involved development and evaluation of an arc-based technique using an emerging technology to effectively delivery focal radiation to multiple brain metastases. In 2013, the Agility linear accelerator (Elekta AB, Stockholm, Sweden) was just coming to market in Canada and consisted of features that could potentially reduce the normal tissue radiation dose received by the brain compared to the existing systems at that time. The primary objective was thus to implement the technique and measure reduction in normal brain tissue radiation dose compared to our standard technique. Additionally, we needed an improved method for quality assurance (QA) of the device to ensure safe treatment. Read more from the final report (PDF)

Read more from this publication, published by the British Institute of Radiology.

<back to 2013 Research Grant Awardees

Share This

Featured Story

Childhood Brain Tumour Signs & Symptoms

Earlier this year, you gave us your feedback in a survey on brain tumour signs and symptoms. One of the things we did with that survey was to compile a list of the most common signs & symptoms for children. Now, as part of Childhood Cancer Awareness Month, we are sharing compelling quotes from that survey and urging you to share them with this link to see the symptoms: www.braintumour.ca/symptoms. Thank you!

Learn more

Spotlight

Anthony's Story is Our Story

I would like to take the opportunity to share "our" story. It’s actually my best friend Anthony's story, but I use the term "our"...

Learn more

Kate's Mum's Story

"May 2006 is a month I will never forget. That was the moment that everything became before the cancer, and after the cancer. It was a...

Learn more

Upcoming Events

  • 17/Oct/2018: Windsor Support Group: Meets at the United Way, Unit A1, 300 Giles Blvd. East... Learn more >
  • 17/Oct/2018: Calgary Support Group: Meets at Wellspring Calgary, 1404 Home Road NW, Calgary, Alberta, T3B 1G7... Learn more >
  • 17/Oct/2018: Niagara Region Support Group: Meets at Wellspring Niagara, 3250 Schmon Parkway, Thorold, ON, L2V 4Y6... Learn more >
  • 17/Oct/2018: Winnipeg Support Group: Sturgeon Creek United Church, 207 Thompson Drive, Winnipeg, MB... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001